Skip to Main Content
Frequently Asked Questions
Submit an ETD
Global Search Box
Need Help?
Keyword Search
Participating Institutions
Advanced Search
School Logo
Files
File List
47971.pdf (3.71 MB)
ETD Abstract Container
Abstract Header
The Immunotherapeutic Approach to Glioblastoma Multiforme
Author Info
Ahad, Leena
ORCID® Identifier
http://orcid.org/0000-0002-5695-8344
Permalink:
http://rave.ohiolink.edu/etdc/view?acc_num=ucin1712915665994219
Abstract Details
Year and Degree
2024, MS, University of Cincinnati, Medicine: Cancer and Cell Biology.
Abstract
Glioblastoma multiforme poses significant treatment challenges, attributed to its distinctive characteristics and immune evasion mechanisms, and carries a grim prognosis despite advancements in therapy. Therefore, rigorous efforts are necessary to uncover additional therapies or other unconventional strategies. Recently, immunotherapies have gained significant traction due to their success in certain malignancies. Immunotherapies use the host's immune system to enhance the ability to combat cancer. These therapies have been in development for over 100 years, and many of them are currently under investigation for treating Glioblastoma multiforme in preclinical and clinical studies. Immunotherapies include antibody therapies, including immune checkpoint blockade, adoptive T cell therapies, cytokine therapies, cancer vaccines, and oncolytic viruses. A deeper understanding of the origins of immunotherapy, immune system dynamics in response to cancer, immune evasion mechanisms of glioblastoma, and the various immunotherapeutic strategies may facilitate the development of novel and effective treatment strategies for glioblastoma. Here, we review the different immunotherapeutic approaches and propose possible combinatory strategies.
Committee
Qing Lu, Ph.D. (Committee Chair)
David Plas, Ph.D. (Committee Member)
Biplab DasGupta, Ph.D. (Committee Member)
David Haslam, M.D. (Committee Member)
Pages
126 p.
Subject Headings
Oncology
Keywords
Glioblastoma multiforme
;
Immunotherapy
;
GBM
;
Immune Evasion
;
Cancer
;
Innate and adaptive immune response to cancer
Recommended Citations
Refworks
EndNote
RIS
Mendeley
Citations
Ahad, L. (2024).
The Immunotherapeutic Approach to Glioblastoma Multiforme
[Master's thesis, University of Cincinnati]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1712915665994219
APA Style (7th edition)
Ahad, Leena.
The Immunotherapeutic Approach to Glioblastoma Multiforme.
2024. University of Cincinnati, Master's thesis.
OhioLINK Electronic Theses and Dissertations Center
, http://rave.ohiolink.edu/etdc/view?acc_num=ucin1712915665994219.
MLA Style (8th edition)
Ahad, Leena. "The Immunotherapeutic Approach to Glioblastoma Multiforme." Master's thesis, University of Cincinnati, 2024. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1712915665994219
Chicago Manual of Style (17th edition)
Abstract Footer
Document number:
ucin1712915665994219
Download Count:
114
Copyright Info
© 2024, all rights reserved.
This open access ETD is published by University of Cincinnati and OhioLINK.